Health
Scientists identify synthetic mini-antibody to combat COVID-19 – Science Codex
The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike protein binds ACE2 using three finger-like protrusions, called the receptor binding domains (RBDs). Blocking the RBDs therefore has the potential to stop the virus from entering human cells. This can be done using antibodies.
Nanobodies, small antibodies found in camels and llamas, are promising as…
-
Noosa News23 hours agoState clears the way for farmland on Brisbane fringe to be developed
-
General18 hours agoPrada to buy rival Versace in $2.3 billion deal
-
Noosa News24 hours agoGout Gout breaks 10 seconds for 100m with illegal tailwind at Australian Athletics Championships
-
Noosa News12 hours agoDutton reportedly targeted in school boy’s alleged terror plot